FDA Approves Assessment Tool to Help Drive Innovation in Premium IOL Cataract Surgery
The U.S. Food and Administration (FDA) last week qualified the American Academy of Ophthalmology’s patient-reported outcome measure for premium intraocular lenses (IOLs) as a Medical Device Development Tool (MDDT).
24-May-2024 12:05 PM EDT
Add to Favorites